NEW YORK, June 20 - Beyond Genomics said yesterday it has chosen Jim Hauske to become its first chief scientific officer.
Hauske, who started on Monday, comes to Beyond Genomics from Sepracor where he was senior vice president for discovery.
Hauske said he expects to help Beyond Genomics build a drug-discovery group in several therapeutic areas. "I'm going to intercept Beyond Genomics' technology with drug-design and drug-development skills that will allow us to more rapidly enter the therapeutic area that the organization cares about," he told GenomeWeb.
Currently the therapeutic areas considered are CNS, oncology, and cardiovascular disorders, according to Stephen Ober, Beyond Genomics' president. "We haven't made a commitment to any area in particular at this point," Ober added.
Click here for more information.